Approximately 19 million U.S. women of childbearing age reside in what are known as “contraceptive deserts” due to geographic, political, economic and social barriers to birth control. Women living in ...

Add Yahoo as a preferred source to see more of our stories on Google. A study has found the contraceptive injection increases risk of brain tumours, as ITV News' Cari Davies reports There is a small ...

Researchers evaluated the association between the use of various hormonal contraceptives and the risk for surgically treated intracranial meningioma.

Researchers are developing an injection that creates a contraceptive implant in the body using an approach that could herald a new way of delivering drugs over long periods of time. Current ...

Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new study has found only about a quarter of reproductive health experts prescribe ...

Researchers at Boston-based Mass General Brigham and MIT have developed a long-acting contraceptive injection designed to be delivered through tiny needles, reducing discomfort and increasing ...

The FINANCIAL — Pfizer Inc. announced on September 24 that the company’s injectable contraceptive, Sayana Press (medroxyprogesterone acetate), is now available to women in the United Kingdom (UK) for ...

A new study has found a link between progestogen medications and an increased risk of brain tumours. The study, which was published in the British Medical Journal (BMJ) by researchers at France’s ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. Sadie Rose, Vogelzang Law’s bankruptcy ...

Guests and partners in the launch of private sector Depo Medroxy Progesterone Subcutaneous( DMPA- SC) contraceptive which is self-injected. [ Jenipher Wachie, Standard] Pharmacies will now serve as ...

NEW YORK (Reuters Health) - A study shows that women who use the injectable contraceptive DMPA (depot medroxyprogesterone acetate) are apt to experience a significant increase in body weight and fat.